Citation Impact
Citing Papers
Selective Targeting of Myeloid-Derived Suppressor Cells in Cancer Patients Using DS-8273a, an Agonistic TRAIL-R2 Antibody
2016
Influence of the Severity of Cognitive Impairment on the Effect of the <i>Ginkgo biloba</i> Extract EGb 761<sup>®</sup> in Alzheimer’s Disease
2002
Development of lipophilic cations as therapies for disorders due to mitochondrial dysfunction
2001
Assessing neuropsychiatric symptoms in people with dementia: a systematic review of measures
2014
Engineering precision nanoparticles for drug delivery
2020 Standout
Antioxidant clinical trials in mild cognitive impairment and Alzheimer's disease
2011
Automatic classification of MR scans in Alzheimer's disease
2008 Standout
Myeloid-derived suppressor cells coming of age
2018 Standout
Oxidative stress, aging, and diseases
2018 Standout
Should We STOP Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptor Blockers in Advanced Kidney Disease?
2016 Standout
Role of ROS and RNS Sources in Physiological and Pathological Conditions
2016 Standout
Hypervalent iodine reagents as a new entrance to organocatalysts
2009 Standout
Dietary Polyphenols and the Prevention of Diseases
2005 Standout
Novel Statistically-Derived Composite Measures for Assessing the Efficacy of Disease-Modifying Therapies in Prodromal Alzheimer’s Disease Trials: An AIBL Study
2015 StandoutNobel
Therapeutic applications of compounds in the Magnolia family
2011 Standout
Medial temporal lobe atrophy and memory dysfunction as predictors for dementia in subjects with mild cognitive impairment
1999
Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity
2021 Standout
Oxidative Nerve Cell Death in Alzheimers Disease and Stroke: Antioxidants as Neuroprotective Compounds
2002
Balancing Acts
2004 Standout
Oxidative stress and the amyloid beta peptide in Alzheimer’s disease
2017 Standout
Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria
2007 Standout
The ADAS-cog in Alzheimer's disease clinical trials: psychometric evaluation of the sum and its parts
2010
Parkinson's disease
2009 Standout
Are delayed‐start design trials to show neuroprotection in Parkinson's disease fundamentally flawed?
2008
Mice with Cardiac-Restricted Angiotensin-Converting Enzyme (ACE) Have Atrial Enlargement, Cardiac Arrhythmia, and Sudden Death
2004 StandoutNobel
Measuring reactive species and oxidative damagein vivoand in cell culture: how should you do it and what do the results mean?
2004 Standout
Oxidative injury in diseases of the central nervous system: focus on alzheimer’s disease
2000
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
Antioxidant Therapy: Current Status and Future Prospects
2011
A review on Alzheimer's disease pathophysiology and its management: an update
2014
Alzheimer's disease
2006 Standout
Melatonin as a natural ally against oxidative stress: a physicochemical examination
2011 Standout
Nanotechnology-based drug delivery systems for the treatment of Alzheimer’s disease
2015
Role of mitochondrial homeostasis and dynamics in Alzheimer's disease
2012
Risk of dementia in diabetes mellitus: a systematic review
2005 Standout
Role of Free Radicals in the Neurodegenerative Diseases
2001 Standout
Alzheimer's Disease
2004 Standout
Preclinical detection of Alzheimer's disease: hippocampal shape and volume predict dementia onset in the elderly
2005
Neurodegenerative diseases and oxidative stress
2004 Standout
Oxidative stress and neurodegeneration: where are we now?
2006 Standout
DEFINING DISEASE MODIFYING THERAPY FOR ALZHEIMER’S DISEASE
2017
Mild cognitive impairment as a diagnostic entity
2004 Standout
Oxidative Stress: Harms and Benefits for Human Health
2017 Standout
Free amino acid and dipeptide changes in the body fluids from Alzheimer’s disease subjects
2006
Assessment and management of behavioral and psychological symptoms of dementia
2015 Standout
An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest
2006 Standout
Molecular Strategies for Targeting Antioxidants to Mitochondria: Therapeutic Implications
2014
Dietary (Poly)phenolics in Human Health: Structures, Bioavailability, and Evidence of Protective Effects Against Chronic Diseases
2012 Standout
Physiology and Pathophysiology of Carnosine
2013 Standout
Comprehensive Review on Alzheimer’s Disease: Causes and Treatment
2020 Standout
Palladium-Catalyzed Intramolecular α-Arylation of α-Amino Acid Esters
2001
Vitamin E and Donepezil for the Treatment of Mild Cognitive Impairment
2005 Standout
Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials.
1995
Exercise and Physical Activity for Older Adults
2009 Standout
Synthesis of Isocoumarins and α-Pyrones via Electrophilic Cyclization
2003 Standout
Putting the Alzheimer's cognitive test to the test II: Rasch Measurement Theory
2012
The neuropathological diagnosis of Alzheimer’s disease
2019 Standout
One-Pot, Modular Approach to Functionalized Ketones via Nucleophilic Addition of Alkyllithium Reagents to Benzamides and Pd-Catalyzed α-Arylation
2016 StandoutNobel
The Role of Oxidative Stress in Neurodegenerative Diseases
2015 Standout
Action of chelators in iron-loaded cardiac cells: accessibility to intracellular labile iron and functional consequences
2006
Targeting the Receptor for Advanced Glycation Endproducts (RAGE): A Medicinal Chemistry Perspective
2017 Standout
Putting the Alzheimer's cognitive test to the test I: Traditional psychometric methods
2012
Practice parameter: Management of dementia (an evidence-based review) [RETIRED]
2001 Standout
Copper-Catalyzed Aerobic Oxidative Intramolecular Alkene C–H Amination Leading to N-Heterocycles
2011
Cell Survival Responses to Environmental Stresses Via the Keap1-Nrf2-ARE Pathway
2006 Standout
Mitochondrial Reactive Oxygen Species (ROS) and ROS-Induced ROS Release
2014 Standout
Polyamines in Drug Discovery: From the Universal Template Approach to the Multitarget-Directed Ligand Design Strategy
2010
Palladium-Catalysed Heteroannulation with Terminal Alkynes: a Highly Regio- and Stereoselective Synthesis of (Z)-3-Aryl(alkyl)idene Isoindolin-1-ones
2000
Synthesis and Pharmacology of Galantamine
2005
Aerobic Copper-Catalyzed Organic Reactions
2013 Standout
Physical Activity and Public Health in Older Adults
2007 Standout
Cardiac βARK1 inhibition prolongs survival and augments β blocker therapy in a mouse model of severe heart failure
2001 StandoutNobel
Transition-Metal-Catalyzed Reactions in Heterocyclic Synthesis
2004 Standout
Magnetic Nanoparticles: Design and Characterization, Toxicity and Biocompatibility, Pharmaceutical and Biomedical Applications
2012 Standout
Antioxidants as treatment for neurodegenerative disorders
2002
Chemistry and Biology Of Multicomponent Reactions
2012 Standout
Oxidative Stress: A Key Modulator in Neurodegenerative Diseases
2019 Standout
Meta-Analysis: High-Dosage Vitamin E Supplementation May Increase All-Cause Mortality
2005 Standout
Works of D. Hadler being referenced
Sustained efficacy and safety of idebenone in the treatment of Alzheimer’s disease: update on a 2-year double-blind multicentre study
1998
A randomized, double-blind, placebo-controlled phase 2 study of tigatuzumab (CS-1008) in combination with carboplatin/paclitaxel in patients with chemotherapy-naïve metastatic/unresectable non-small cell lung cancer
2013
Safety and Efficacy of Idebenone versus Tacrine in Patients with Alzheimer's Disease: Results of a Randomized, Double-Blind, Parallel-Group Multicenter Study
2002
A Controlled Study of 2 Doses of Idebenone in the Treatment of Alzheimer’s Disease
1997
Alzheimer’s Disease Assessment Scale: Reliability and Validity in a Multicenter Clinical Trial
1997
Protocols to demonstrate slowing of Alzheimer disease progression. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines. The Disease Progression Sub-Group.
1997
Long-Term Treatment of Severe Chronic Heart Failure with Captopril
1987
Randomized, double-blind, placebo-controlled trial of the efficacy and tolerability of a new isoindoline derivative (DN-2327) in generalized anxiety
1997
Plasma LPI in β-Thalassemia Patients before and after Treatment with Deferasirox (Exjade®, ICL670).
2005
Measuring behavior, mood, and psychiatric symptoms in Alzheimer disease.
1997